Connecting Research and Experts with Journalists

• share
• favorite_border

Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary arteries. Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine.

• share
• favorite_border

Retrofitting a portion of the US shipping fleet from internal combustion engines to battery-electric systems could significantly reduce greenhouse gas emissions and be largely cost effective by 2035, according to a new study from Berkeley Lab researchers.

• share
• favorite_border

A new, large study led by American Cancer Society (ACS) researchers found that lack of health insurance coverage accounts for a significant proportion of racial and ethnic disparities in advanced-stage diagnosis of multiple cancers.

• share
• favorite_border

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The study, published in the October 30 online issue of Cell used a cutting-edge spatial genomics technology and preclinical animal models, with tumor specimens from ovarian cancer patients further validating the findings. They found that ovarian cancer cells produce a molecule called Interleukin-4 (IL-4), which is typically associated with asthma and the skin condition eczema, also known as atopic dermatitis. The study went on to find that the cancer cells used IL-4 to create a protective environment that kept away killer immune cells, making the tumors resistant to immunotherapy. A drug, dupilumab, which blocks IL-4’s activity, has been approved by the Food and Drug Administration (FDA) and is already used to treat asthma and eczema. This new study suggests dupi

• share
• favorite_border

A new initiative by the American Academy of Dermatology aims to shed light on an often misunderstood and debilitating condition, hidradenitis suppurativa (HS). HS is a chronic progressive condition that can cause painful and boil-like bumps, particularly in a patient’s armpits, thighs, and groin.

• share
• favorite_border

A research team has established a Virus-Induced Gene Silencing (VIGS) system in taro, enabling researchers to rapidly verify gene functions in this underutilized crop.

• share
• favorite_border

Nitin Yerram, MD, co-director of urologic oncology at JTCC, received a grant from Artera to assess the MMAI platform for estimating prostate cancer aggressiveness in men who have had a prostate biopsy and underwent surgery.

• share
• favorite_border

An international team of imaging, engineering and cancer experts is developing a novel mobile breast cancer diagnostic kit to improve early diagnosis in low- and middle-income countries — such as Uganda, where systemic delays lead to an advanced stage diagnosis in 70% of breast cancer cases.  

• share
• favorite_border

Following a year marked by stronger than expected output and improvement in tackling inflation, the U.S. economy will reach its equilibrium growth rate in 2025 and supply and demand will finally come back into balance after taking major hits during the COVID-19 pandemic, according to an economic forecast from the Indiana University Kelley School of Business.

• share
• favorite_border

In the quest for more efficient electronic devices, heat dissipation has become a critical issue. A new study presents a significant advancement in the preparation of thermal conductive polymer composites containing liquid metal, offering a solution to the persistent challenge of heat management in high-power electronics.